CN103638485B - One treats the dyspeptic Chinese medicine composition of hepatopath - Google Patents
One treats the dyspeptic Chinese medicine composition of hepatopath Download PDFInfo
- Publication number
- CN103638485B CN103638485B CN201310597932.4A CN201310597932A CN103638485B CN 103638485 B CN103638485 B CN 103638485B CN 201310597932 A CN201310597932 A CN 201310597932A CN 103638485 B CN103638485 B CN 103638485B
- Authority
- CN
- China
- Prior art keywords
- parts
- hepatopath
- radix
- rhizoma
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to one and treat the dyspeptic Chinese medicine composition of hepatopath, be made up of according to weight fraction following component: Rhizoma Atractylodis 30-40 part, Cortex Magnoliae Officinalis 30-40 part, Fructus Chaenomelis 30-40 part, Massa Medicata Fermentata 30-40 part, Rhizoma Cyperi 20-30 part, Radix Bupleuri 20-30 part, Flos Rosae Chinensis 20-30 part, Radix Linderae 20-30 part, Rhizoma Zingiberis Recens 10-20 part, Radix Gentianae 10-20 part.The dyspeptic Chinese medicine composition for the treatment of hepatopath of the present invention, reasonable recipe, in side, Rhizoma Atractylodis are drying damp and strengthening spleen, Cortex Magnoliae Officinalis circulation of qi promoting, dampness, removing food stagnancy, Fructus Chaenomelis removing dampness to restore normal function of the stomach, and Massa Medicata Fermentata helps digestion stomach function regulating, and four medicines are monarch drug altogether; Rhizoma Cyperi depressed liver-energy dispersing and QI regulating, menstruction regulating and pain relieving, Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI, Flos Rosae Chinensis promoting blood flow to regulate menstruation, resolving depression is subsided a swelling, Radix Linderae promoting the circulation of QI to relieve pain, four medicines are ministerial drug altogether, Rhizoma Zingiberis Recens relieving the exterior syndrome by diaphoresis, warming middle-JIAO to arrest vomiting, Radix Gentianae heat clearing and damp drying, removing fire from the liver, be adjuvant drug altogether, ten medicines share, and play effect of dampness, spleen invigorating, stomach function regulating, dispersing the stagnated live-QI to relieve the stagnation of QI altogether.Drug use of the present invention is convenient, Be very effective, effectively the disease for the treatment of hepatopath dyspepsia.
Description
Technical field
The present invention relates to Chinese medicine composition, particularly one treats the dyspeptic Chinese medicine composition of hepatopath.
Background technology
By the dysfunction of the incomplete caused aspect such as gastral motion, absorption, secretion, barrier, blood circulation of liver function, be referred to as liver property Gut peptides, a lot of hepatopath is usually that onset symptoms is gone to a doctor with dyspepsia; And the functional dyspepsia meeting Rome III diagnostic criteria is common especially clinically.Most dyspepsia patient has period of digestion and interdigestive phase dyskinesia, and gastric emptying is the leading indicator evaluating period of digestion function.
Hepatopath's dyspepsia main manifestations is side of body rib distension pain, uncomfortable in chestly heaves a deep sigh, spirit depressing, irascible temperament, decreased food intake of receiving is few, and tastelessness is dull, the vexed abdominal distention of gastral cavity, afternoon is very, deficiency of QI with disinclination to talk, extremity asthenia, shallow complexion, diarrhea or food indigested food, often increase the weight of because taking food the greasy and stodgy food of raw food.Pale tongue has indentation, and tongue is white, deep and stringy pulse.
Summary of the invention
For the defect existed in prior art, one is the object of the present invention is to provide to treat the dyspeptic Chinese medicine composition of hepatopath.
Technical scheme of the present invention is as follows:
One treats the dyspeptic Chinese medicine composition of hepatopath, is made up of according to weight fraction following component:
Rhizoma Atractylodis 30-40 part, Cortex Magnoliae Officinalis 30-40 part, Fructus Chaenomelis 30-40 part, Massa Medicata Fermentata 30-40 part, Rhizoma Cyperi 20-30 part, Radix Bupleuri 20-30 part, Flos Rosae Chinensis 20-30 part, Radix Linderae 20-30 part, Rhizoma Zingiberis Recens 10-20 part, Radix Gentianae 10-20 part.
The dyspeptic Chinese medicine composition for the treatment of hepatopath as above, is made up of according to weight fraction following component:
Rhizoma Atractylodis 35 parts, Cortex Magnoliae Officinalis 35 parts, Fructus Chaenomelis 35 parts, Massa Medicata Fermentata 35 parts, Rhizoma Cyperi 25 parts, Radix Bupleuri 25 parts, Flos Rosae Chinensis 25 parts, the Radix Linderae 25 parts, 15 parts, Rhizoma Zingiberis Recens, Radix Gentianae 15 parts.
The dyspeptic Chinese medicine composition for the treatment of hepatopath of the present invention, reasonable recipe, in side, Rhizoma Atractylodis are drying damp and strengthening spleen, Cortex Magnoliae Officinalis circulation of qi promoting, dampness, removing food stagnancy, Fructus Chaenomelis removing dampness to restore normal function of the stomach, and Massa Medicata Fermentata helps digestion stomach function regulating, and four medicines are monarch drug altogether; Rhizoma Cyperi depressed liver-energy dispersing and QI regulating, menstruction regulating and pain relieving, Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI, Flos Rosae Chinensis promoting blood flow to regulate menstruation, resolving depression is subsided a swelling, Radix Linderae promoting the circulation of QI to relieve pain, four medicines are ministerial drug altogether, Rhizoma Zingiberis Recens relieving the exterior syndrome by diaphoresis, warming middle-JIAO to arrest vomiting, Radix Gentianae heat clearing and damp drying, removing fire from the liver, be adjuvant drug altogether, ten medicines share, and play effect of dampness, spleen invigorating, stomach function regulating, dispersing the stagnated live-QI to relieve the stagnation of QI altogether.Drug use of the present invention is convenient, Be very effective, effectively the disease for the treatment of hepatopath dyspepsia.
Detailed description of the invention
Embodiment 1
One treats the dyspeptic Chinese medicine composition of hepatopath, is made up of (every part of 1g) according to weight fraction following component:
Rhizoma Atractylodis 30 parts, Cortex Magnoliae Officinalis 30 parts, Fructus Chaenomelis 30 parts, Massa Medicata Fermentata 30 parts, Rhizoma Cyperi 20 parts, Radix Bupleuri 20 parts, Flos Rosae Chinensis 20 parts, the Radix Linderae 20 parts, 10 parts, Rhizoma Zingiberis Recens, Radix Gentianae 10 parts.
Preparation method is as follows:
Take various component in above-mentioned composition according to quantity, join in 800 parts of water, boil 30 minutes, filter, abandon filtering residue, filtrate is concentrated into 200 parts.
Embodiment 2
The dyspeptic Chinese medicine composition for the treatment of hepatopath as above, is made up of (every part of 1g) according to weight fraction following component:
Rhizoma Atractylodis 35 parts, Cortex Magnoliae Officinalis 35 parts, Fructus Chaenomelis 35 parts, Massa Medicata Fermentata 35 parts, Rhizoma Cyperi 25 parts, Radix Bupleuri 25 parts, Flos Rosae Chinensis 25 parts, the Radix Linderae 25 parts, 15 parts, Rhizoma Zingiberis Recens, Radix Gentianae 15 parts.
Preparation method is with embodiment 1.
Embodiment 3
One treats the dyspeptic Chinese medicine composition of hepatopath, is made up of (every part of 1g) according to weight fraction following component:
Rhizoma Atractylodis 40 parts, Cortex Magnoliae Officinalis 40 parts, Fructus Chaenomelis 40 parts, Massa Medicata Fermentata 40 parts, Rhizoma Cyperi 30 parts, Radix Bupleuri 30 parts, Flos Rosae Chinensis 30 parts, the Radix Linderae 30 parts, 20 parts, Rhizoma Zingiberis Recens, Radix Gentianae 20 parts.
Preparation method is with embodiment 1.
Experimental example
Choose in hepatopath patient 80 example with indigestion symptom, take medicine prepared by the embodiment of the present invention 2, every day twice, each 50g 7 days was 1 course for the treatment of, and after taking for two courses for the treatment of continuously, 21 examples are cured, and effectively, 3 examples are invalid, total effective rate 96.3% for 56 examples.
Claims (2)
1. treat the dyspeptic Chinese medicine composition of hepatopath, it is characterized in that being made up of according to parts by weight following component:
Rhizoma Atractylodis 30-40 part, Cortex Magnoliae Officinalis 30-40 part, Fructus Chaenomelis 30-40 part, Massa Medicata Fermentata 30-40 part, Rhizoma Cyperi 20-30 part, Radix Bupleuri 20-30 part, Flos Rosae Chinensis 20-30 part, Radix Linderae 20-30 part, Rhizoma Zingiberis Recens 10-20 part, Radix Gentianae 10-20 part.
2. the dyspeptic Chinese medicine composition for the treatment of hepatopath according to claim 1, is characterized in that being made up of according to parts by weight following component:
Rhizoma Atractylodis 35 parts, Cortex Magnoliae Officinalis 35 parts, Fructus Chaenomelis 35 parts, Massa Medicata Fermentata 35 parts, Rhizoma Cyperi 25 parts, Radix Bupleuri 25 parts, Flos Rosae Chinensis 25 parts, the Radix Linderae 25 parts, 15 parts, Rhizoma Zingiberis Recens, Radix Gentianae 15 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310597932.4A CN103638485B (en) | 2013-11-22 | 2013-11-22 | One treats the dyspeptic Chinese medicine composition of hepatopath |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310597932.4A CN103638485B (en) | 2013-11-22 | 2013-11-22 | One treats the dyspeptic Chinese medicine composition of hepatopath |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103638485A CN103638485A (en) | 2014-03-19 |
| CN103638485B true CN103638485B (en) | 2015-11-18 |
Family
ID=50243857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310597932.4A Expired - Fee Related CN103638485B (en) | 2013-11-22 | 2013-11-22 | One treats the dyspeptic Chinese medicine composition of hepatopath |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103638485B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104197646A (en) * | 2014-08-25 | 2014-12-10 | 济南康众医药科技开发有限公司 | Drying method of magnolia officinalis and application of magnolia officinalis product |
| CN104180611A (en) * | 2014-08-25 | 2014-12-03 | 济南康众医药科技开发有限公司 | Application of freeze-drying technology in mangnolia officinalis |
| CN104154718A (en) * | 2014-08-25 | 2014-11-19 | 济南康众医药科技开发有限公司 | Drying method of cortex magnoliae officinalis |
-
2013
- 2013-11-22 CN CN201310597932.4A patent/CN103638485B/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 中医药对功能性消化不良的整体研究;王晓敏 等;《甘肃科技》;20080623;第24卷(第12期);146-149 * |
| 香乌汤治疗功能性消化不良62例;宋跃龙;《湖北中医杂志》;20040310;第26卷(第3期);45 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103638485A (en) | 2014-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101496887B (en) | Medicament for treating acute hot, itching and wet severe type and chronic urticaria | |
| CN103055260B (en) | Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof | |
| CN103638485B (en) | One treats the dyspeptic Chinese medicine composition of hepatopath | |
| CN104043009A (en) | Medicine for treating stomach disease | |
| CN103479947B (en) | The preparation method of control constipation medicine | |
| CN104147524A (en) | Traditional Chinese medicine preparation for treating peptic ulcer | |
| CN103893457A (en) | Traditional Chinese medicine for treating ulcerative colitis | |
| CN103550684B (en) | A kind of Chinese medicine composition for the treatment of stomach carbuncle | |
| CN104056171B (en) | The Chinese medicine for the treatment of infantile malnutrition | |
| CN102961696B (en) | Chinese medicinal composition for treating diabetic nephropathy edema | |
| CN105031580A (en) | Traditional Chinese medicine formula for treating chronic non-atrophic gastritis, stomach ulcer and duodenal ulcer caused by deficiency cold of spleen and stomach | |
| CN104667243A (en) | Traditional Chinese medicament for treating ulcerative colitis | |
| CN105343806A (en) | Traditional Chinese medicine preparation for treating gastritis and gastric ulcer | |
| CN104971302A (en) | Traditional Chinese medicine composition for treating biliary tract ascariasis | |
| CN104306523A (en) | Yao drug preparation for treating chronic pelvic inflammation and preparation method thereof | |
| CN103599508B (en) | One is used for the treatment of the uremic Chinese medicine composition of children's | |
| WO2015003340A1 (en) | Traditional chinese medicine for treating cirrhosis ascites | |
| CN107929683A (en) | A kind of Chinese medicine composition for treating infantile anaphylactic cough and preparation method thereof | |
| CN103446570B (en) | One treats chronic bronchitis Chinese medicine | |
| CN106266774A (en) | A kind of Traditional Chinese medicinal spray treating edema or edema disease | |
| CN105288528A (en) | Medicinal liquor for treating spleen-stomach disharmony | |
| CN105797044A (en) | Traditional Chinese medicinal composition for treating gastric ulcer | |
| CN106581358A (en) | Chinese medicine prescription for treating liver and stomach disharmony-type indigestion | |
| CN105194213A (en) | Traditional Chinese medicine for treating chronic abdominal pain and diarrhea and preparation method thereof | |
| CN105250805A (en) | Traditional Chinese medicine for treating postpartum hypogalactia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151118 Termination date: 20161122 |